AGI.do

CompanyTypes

What will AGI do for Biopharma Royalty Aggregators?

Key roles: Managing Director, Royalty Acquisitions, VP of Deal Origination, VP of Clinical Diligence, Scientific Director, Valuation Principal, Commercial Forecasting Director, Chief IP Counsel, Patent Diligence Counsel, Royalty Audit Manager, Alliance Manager, Market Access Analyst, Director of Tax Structuring, Head of Capital Formation. Departments: Deal Origination, Clinical Due Diligence, Valuation & Commercial Forecasting, IP & Transactional Law, Royalty Management & Collections, Alliance Management, Tax & Corporate Structuring, Treasury & Capital Markets.

How AGI delivers it

Four ways AGI delivers for Biopharma Royalty Aggregators

  • Business-as-Code

    Encode how your work runs, once, as software that executes itself.

    For Biopharma Royalty Aggregators, encode how your work runs, once, as software that executes itself.

  • Autonomous Agents as digital employees

    Hire a digital employee that does the job under earned, supervised autonomy.

    For Biopharma Royalty Aggregators, hire a digital employee that does the job under earned, supervised autonomy.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Biopharma Royalty Aggregators, get the professional outcome delivered as software, priced on results, not headcount.

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Biopharma Royalty Aggregators, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

Go deeper

Explore Biopharma Royalty Aggregators

Read the deeper take on agi.asView as markdown